ramucirumab
Showing 151 - 163 of 163
Colorectal Carcinoma Trial in Chiba, Osaka, Shizuoka (Ramucirumab (IMC-1121B), Irinotecan, levofolinate)
Completed
- Colorectal Carcinoma
- Ramucirumab (IMC-1121B)
- +3 more
-
Chiba, Japan
- +2 more
Oct 3, 2014
Malignant Solid Tumor Trial in United States (Ramucirumab, Docetaxel)
Hepatocellular Carcinoma Trial in United States (Ramucirumab (IMC-1121B))
Completed
- Hepatocellular Carcinoma
- Ramucirumab (IMC-1121B)
-
Los Angeles, California
- +5 more
Sep 29, 2014
Adenocarcinoma Trial in Chiba, Osaka (Ramucirumab (IMC-1121B ), Paclitaxel)
Breast Cancer, Metastatic Breast Cancer Trial in Japan (Ramucirumab, Docetaxel)
Completed
- Breast Cancer
- Metastatic Breast Cancer
- Ramucirumab
- Docetaxel
-
Hidaka, Japan
- +3 more
May 16, 2014
Metastatic Malignant Melanoma Trial in United States (IMC-1121B (ramucirumab), Dacarbazine)
Completed
- Metastatic Malignant Melanoma
- IMC-1121B (ramucirumab)
- Dacarbazine
-
Decatur, Alabama
- +16 more
Jul 29, 2014
Colorectal Carcinoma Trial in Canada, Spain (IMC-1121B (ramucirumab), Oxaliplatin, Folinic acid)
Completed
- Colorectal Carcinoma
- IMC-1121B (ramucirumab)
- +3 more
-
Ottawa, Ontario, Canada
- +6 more
May 16, 2014
Metastatic Renal Cell Carcinoma Trial in United States (Ramucirumab)
Completed
- Metastatic Renal Cell Carcinoma
- Ramucirumab
-
San Francisco, California
- +10 more
May 16, 2014
Advanced Solid Tumors Trial in Tokyo (IMC-1121B)
Completed
- Advanced Solid Tumors
- IMC-1121B
-
Tokyo, JapanImClone Investigational Site
May 16, 2014
Stomach Cancer, Esophageal Cancer Trial in United States (Ramucirumab, Placebo, Oxaliplatin)
Completed
- Stomach Cancer
- Esophageal Cancer
- Ramucirumab
- +4 more
-
Anchorage, Alaska
- +57 more
Oct 3, 2014
Advanced Solid Tumors Trial in Aurora, Philadelphia (IMC-1121B, 1121B)
Completed
- Advanced Solid Tumors
- IMC-1121B
- 1121B
-
Aurora, Colorado
- +1 more
Aug 16, 2013
Cancer Trial in Indianapolis, Durham, Philadelphia (IMC-1121B, 1121B)
Completed
- Cancer
- IMC-1121B
- 1121B
-
Indianapolis, Indiana
- +2 more
Aug 16, 2013